Efficacy and Safety of Ivarmacitinib in the Treatment of Patients With Polymyalgia Rheumatica

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
The study intends to explore the efficacy and safety of Ivarmacitinib in therapy for polymyalgia rheumatica through a multicenter, randomized, double-blind, placebo-controlled study, and to explore the effectiveness of Ivarmacitinib as an oral glucocorticoid-sparing alternative in the treatment of polymyalgia rheumatica.
Epistemonikos ID: 584d425f35957ffa19e69861e4a51dc52ab16b67
First added on: Dec 06, 2025